2022 （第六届）RWE真实世界研究峰会
梅斯医学和生物谷自创立以来，始终致力于打造医药行业深度交流学习平台，并为推动真实世界研究的整体规范发展不断努力。自2017年至今，RWE峰会已成功举办五届，线上线下累计覆盖3万+人次。邀请来自政府指导单位、专业学术机构、临床及统计专家、企业医学高层管理者，为参会嘉宾带来政策深度解析，为真实世界研究的整体规范化发展贡献力量。
2021 RWE真实世界研究峰会（第五届）
2021RWE真实世界研究峰会（第五届）将于4月23日-4月24日在上海召开，本次会议主题为“创新 变革 规范”，用创新的态度，顺势应变，推动真实世界研究的规范发展。
2020（第四届）RWE真实世界研究峰会
2020 RWE真实世界研究峰会（第四届）将于9月18日-9月19日在上海召开，本次会议主题为“变革之下，聚焦创新”，谨代表组委会诚挚邀请您出席本次会议。
2020年伴随着一场突如其来的疫情给全球医疗环境带来的巨大挑战，医药大环境也发生了急剧变化，国家大力推进医药卫生体制改革。着眼于临床治疗规范性的提升与药物应用水平的提高，医药企业如何在独特的医药大环境下顺应形势开展符合本土特色的真实世界研究？
近年来，真实世界研究的实践案例不断增多，在践行证据驱动营销、强化产品整体竞争力的道路上，政策制定者、学院专家、制药企业分别有怎样的规划和考量？
生物谷自成立以来，始终致力于打造医药行业深度交流学习平台，并为推动真实世界研究的整体发展不断努力着。2020RWE真实世界峰会（第四届）将于9月在上海召开。鉴于您在该领域的卓越影响力，我们诚挚地邀请您出席此次会议，分享宝贵经验，与众多专家和行业人士相聚于此，共谋发展！
Meta分析实战训练营-第十一期【2020.06.19-21】
1.提高文献的纳入和数据的采集，达到数据的客观有效。 2.掌握使用meta分析软件，学会自己写作。 3.建立循证思维以及培养科研思维。 4.掌握预研究的目标问题的研究现状。 5.掌握Meta分析结构化写作。
2020 (11th) International Conference on Cell Therapy
Focus on stem cell & regenerative medicine, CAR-T , cancer immunotherapy, gene therapy, and more.
The Wuxi International Bioforum 2019 and The 9th Cell Death & Disease Symposium - New Drug Discovery
Internationally renowned leading scientists and pioneers will present cutting-edge advances in cancer immunotherapy, targeted therapy with small molecules,and/or monoclonal antibodies, and novel cell therapeutic strategies. . New challenges, topical directions and novel approacheswill be discussed.
2019 (10th) International Conference on Cell Therapy
Although cell therapy has been on its fast lane, all colleagues in this field still have a long way to go due to the difficulty in treatment of solid tumors and the high cost of T cells. It is believed that many people are looking forward to the approval of Chinese cell therapy products.
2019 (5th) International Conference on Gut Microecology and Health
At present, gut microbiome is a hot topic, which draws much attention. Due to its curative effects on multiple diseases, gut microbiome is closely related to human health. Under the development of microbe imaging, metabolomics and single-cell sequencing technologies, new progress has been made in this field.
2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.